The Only Complete Online Marketing Firm
Thursday, September 15, 2016
EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE)
(MedPage Today) -- Ertugliflozin improved T2D control atop metformin/sitagliptin
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment